Quadramet

 

Topic mentions per year

Topic mentions per year

2001-2018
01220012018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PSA-TRICOM is a therapeutic vaccine in late stage clinical testing in metastatic castration-resistant prostate cancer (mCRPC… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2009
2009
Abstract Bone-seeking radiopharmaceuticals and bisphosphonates may be indicated in patients with cancer with painful osseous… (More)
Is this relevant?
Review
2007
Review
2007
Radiation therapy can be an effective means to treat bone metastases, which occur in more than 50% of cancer patients. (153… (More)
Is this relevant?
2006
2006
Crystals of Eu(III) with ethylenediaminetetra(methylenephosphonic acid) (H(8)EDTMP) and with ethylenediaminetetraacetic acid (H(4… (More)
Is this relevant?
2005
2005
Osteoblastic metastases and osteosarcoma can avidly concentrate bone-seeking radiopharmaceuticals. We sought to increase… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 4
Is this relevant?
2005
2005
OBJECTIVE To evaluate the cost-effectiveness of samarium [153Sm-EDTMP] (Quadramet) compared to conventional therapy in the… (More)
Is this relevant?
2004
2004
BACKGROUND Transplantation tolerance, defined as acceptance of a graft by an otherwise fully immunocompetent host, has been an… (More)
Is this relevant?
2004
2004
4732 Background: Though metastatic prostate cancer (PCa) is a systemic disorder, bone disease predominates in its clinical… (More)
Is this relevant?
2002
2002
Standard treatment regimens for haematological malignancies include myeloablative chemoradiotherapy and subsequent rescue by stem… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Review
2001
Review
2001
Although bone pain from osteoblastic metastases can be ameliorated 50% to 80% of the time by use of intravenously or orally… (More)
Is this relevant?